Is Health Catalyst, Inc. (HCAT) a Buy, Sell, or Hold?
NASDAQ : HCAT
Health Catalyst, Inc.
$2.085 USD
-$0.07 (-3.47%)
- Volume
- 358.5K
- Average Volume
- 1.55M
- Market Capitalization
- $154.07M
- P/E Ratio
- -0.56
- Dividend Yield
- 0.00%
- Price Target
- $2.38
- Year High
- $4.12
- Year Low
- $0.96
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.69
Company Overview
NASDAQ
Benjamin Albert
Medical - Healthcare Information Services
Healthcare
HCAT
1200
US
USD
Liquidity Metrics
1.23
1.69
1.69
0.56
0.00
Sales & Valuation
$311.14M
0.51
1.10
16.80
0.13
Profitability
-$2.55
-$177.97M
-87.69%
-87.39%
-99.78%
-64.35%
P/E Metrics
-0.56
0.01
0.01
Analyst Price Target & Rating
$2.38
$3.00
$1.75
2/5
22 Analysts
-12.21%
Financial Health Scores
-5.64
4/9
$74.7M
$412.2M
$274.06M
-$242.66M
Key Metrics (TTM)
$270.33M
0.89
-1.41
1.69
-99.78%
-18.74%
-169.17%
5.75%
45 days
Company Executives
| Name | Title |
|---|---|
| Benjamin Albert | Chief Executive Officer & Director |
| Benjamin Landry | General Counsel & Secretary of the Board |
| Jason Alger | Chief Financial Officer |
| Kyle J. Salyers | Chief Strategy Officer & Senior Vice President of Corporate Development |
| Jeffrey Selander | Senior Vice President of International |
| Holly Rimmasch | Senior Vice President & Chief Clinical Officer |
| Sadiqa Mahmood | GM & Senior VP of Life Sciences Business |
| Linda Llewelyn | Senior Advisor |
| Kristen Berry | Senior Vice President of Public Relations |
| Carrie Kozlowski | Chief Marketing Officer |
Poll Results
No votes yet today — be the first to share your view!
About Health Catalyst, Inc. (NASDAQ:HCAT) Stock
Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial intelligence (AI) and data science solutions that integrate AI seamlessly into existing business intelligence tools, thereby enhancing analytical precision. The company's services also cover population health management, which identifies areas for improvement throughout the patient care journey, offering actionable recommendations and automated processes. For financial effectiveness, they provide critical insights into cost analysis, workforce efficiency, and revenue maximization. ... Moreover, Health Catalyst contributes to improving quality and safety by leveraging clinical and patient safety data, sophisticated analytics, and expert consulting. They also facilitate a national data ecosystem, promoting collaborative thought leadership and shared knowledge to generate groundbreaking insights that redefine healthcare delivery. Established in 2008 and based in South Jordan, Utah, the company was formerly known as HQC Holdings, Inc. before officially becoming Health Catalyst, Inc. in March 2017.
Health Catalyst Investors Approve Directors, Pay; Board Declassification Fails
2026-07-16 18:03:59
Health Catalyst NASDAQ: HCAT stockholders approved three of four proposals presented at the company's 2026 annual meeting, including the election of two directors, ratification of the company's auditor and an advisory vote on executive compensation. A proposal to phase out the company's classified board structure did not receive the required level of support.
Health Catalyst to Participate in Upcoming Investor Conference
2026-06-16 16:05:00
SALT LAKE CITY, June 16, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that members of senior management will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference, including a panel discussion titled “AI ROI in Healthcare: Real vs Hype Debate,” with Ben Albert, Chief Executive Officer, on Wednesday, June 24, 2026, at 3:30pm ET.
2026-06-04 10:06:00
PARSIPPANY, N.J., June 4, 2026 /PRNewswire/ -- Med-Metrix, LLC ("Med-Metrix"), backed by Harvest Partners and A&M Capital Partners, today announced it has entered into a definitive agreement to acquire Vitalware, an industry-leading revenue workflow and analytics software business owned by Health Catalyst (NASDAQ: HCAT).
Health Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic Transformation
2026-06-04 09:03:00
Health Catalyst today announced it has signed a definitive agreement to divest Vitalware, its mid-revenue cycle business, to Med-Metrix for $147 million.
Health Catalyst, Inc. (HCAT) Q1 2026 Earnings Call Transcript
2026-05-12 06:01:37
Health Catalyst, Inc. (HCAT) Q1 2026 Earnings Call Transcript
Health Catalyst Q1 Earnings Call Highlights
2026-05-11 20:09:45
Health Catalyst NASDAQ: HCAT reported first-quarter 2026 results that topped its own expectations, while management outlined a broad restructuring plan aimed at simplifying the company's operating model, reducing costs and shifting the business further toward technology-led growth.
Health Catalyst (HCAT) Q1 Earnings and Revenues Surpass Estimates
2026-05-11 19:06:21
Health Catalyst (HCAT) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to earnings of $0.01 per share a year ago.
Compared to Estimates, Health Catalyst (HCAT) Q1 Earnings: A Look at Key Metrics
2026-05-11 19:01:17
While the top- and bottom-line numbers for Health Catalyst (HCAT) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Frequently Asked Questions
-
What is the current Health Catalyst, Inc. (HCAT) stock price?
-
Health Catalyst, Inc.(NASDAQ:HCAT) stock price is $2.085 in the last trading session. During the trading session, HCAT stock reached the peak price of $4.115 while $0.955 was the lowest point it dropped to. The percentage change in HCAT stock occurred in the recent session was --3.47% while the dollar amount for the price change in HCAT stock was -$0.07.
-
HCAT's industry and sector of operation?
-
The NASDAQ listed HCAT is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector.
-
Who are the executives of HCAT?
-
Benjamin Albert | Chief Executive Officer & Director
Benjamin Landry | General Counsel & Secretary of the Board
Jason Alger | Chief Financial Officer
Kyle J. Salyers | Chief Strategy Officer & Senior Vice President of Corporate Development
Jeffrey Selander | Senior Vice President of International -
How many employees does HCAT have?
-
Number of HCAT employees currently stands at 1200. HCAT operates from 10897 South River Front Parkway, South Jordan, UT 84095, US.
-
Link for HCAT official website?
-
Official Website of HCAT is: https://www.healthcatalyst.com
-
How do I contact HCAT?
-
HCAT could be contacted at phone #801 708 6800 and can also be accessed through its website. HCAT operates from 10897 South River Front Parkway, South Jordan, UT 84095, US.
-
How many shares of HCAT are traded daily?
-
The average number of HCAT shares traded daily for last 3 months was 1.55M.
-
What is the market cap of HCAT currently?
-
The market value of HCAT currently stands at $154.07M with its latest stock price at $2.085